- Home
- IMRN vs MI Comparison
IMRN vs MI Comparison
Compare IMRN & MI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRN
- MI
- Stock Information
- Founded
- IMRN 1994
- MI 2009
- Country
- IMRN Australia
- MI Hong Kong
- Employees
- IMRN N/A
- MI N/A
- Industry
- IMRN Biotechnology: Pharmaceutical Preparations
- MI Catalog/Specialty Distribution
- Sector
- IMRN Health Care
- MI Consumer Discretionary
- Exchange
- IMRN Nasdaq
- MI Nasdaq
- Market Cap
- IMRN 9.2M
- MI N/A
- IPO Year
- IMRN N/A
- MI N/A
- Fundamental
- Price
- IMRN $1.70
- MI $2.18
- Analyst Decision
- IMRN Strong Buy
- MI
- Analyst Count
- IMRN 1
- MI 0
- Target Price
- IMRN $5.00
- MI N/A
- AVG Volume (30 Days)
- IMRN 25.4K
- MI 7.8K
- Earning Date
- IMRN 07-07-2025
- MI 01-01-0001
- Dividend Yield
- IMRN N/A
- MI N/A
- EPS Growth
- IMRN N/A
- MI N/A
- EPS
- IMRN N/A
- MI 1.53
- Revenue
- IMRN $4,048,286.00
- MI $740,701.00
- Revenue This Year
- IMRN N/A
- MI N/A
- Revenue Next Year
- IMRN N/A
- MI N/A
- P/E Ratio
- IMRN N/A
- MI $1.42
- Revenue Growth
- IMRN 82.90
- MI N/A
- 52 Week Low
- IMRN $1.50
- MI $1.57
- 52 Week High
- IMRN $2.87
- MI $10.29
- Technical
- Relative Strength Index (RSI)
- IMRN 42.03
- MI 43.14
- Support Level
- IMRN $1.56
- MI $2.10
- Resistance Level
- IMRN $1.96
- MI $2.49
- Average True Range (ATR)
- IMRN 0.11
- MI 0.11
- MACD
- IMRN -0.01
- MI -0.00
- Stochastic Oscillator
- IMRN 35.00
- MI 31.11
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.